Top

Gepubliceerd in:

01-12-2006 | Artikelen

Gezondheidsproblemen na de behandeling van kinderkanker

Auteurs: A. Postma, A. Y. N. Schouten-van Meeteren, F. G. A. J. Hakvoort-Cammel, D. Bresters, A. B. Versluys, J. P. M. Bökkerink, E. van Dulmen-den Broeder, H. J. H. van der Pal, E. W. C. M. van Dam, G. H. M. van der Linden, R. Blaauwbroek, F. E. van Leeuwen, M. W. M. Jaspers, L. C. M. Kremer, C. van den Bos

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 6/2006

Samenvatting

Childhood cancer survivors are at increased risk for adverse late effects due to the tumour itself or secondary to treatment with chemotherapy and/or radiotherapy. In the Netherlands paediatric oncology centres have established dedicated late effects clinics. Here specialised care is offered to the survivors, who are also screened for unknown late effects. If necessary, survivors are referred for further diagnostic work-up and treatment. Furthermore the paediatric oncology centres are exploring ways to provide adequate care for adult survivors. Finally, the centres are initiating research in the field of late treatment effects. Two representative case histories are presented.

vorige artikel Vroeggeboorte, intra-uteriene groeiachterstand en lichamelijke ziekten op de volwassen leeftijd; resultaten van 19 jaar pops-follow-up

volgende artikel Landelijke richtlijnen voor follow-up van overlevenden van kinderkanker

Curry HL, Parkes SE, Powell JE, et al. Caring for survivors of childhood cancer: The size of the problem. Eur J Cancer. 2006;42:501-8.CrossRef

Hewitt MWS, Simone JV, eds. Childhood cancer survivorship: improving care and quality of life. Washington: National Academic Press, 2003.

Meadows AT, Krejmas NL, Belasco JB. The medical cost of cure: sequelae in survivors of childhood cancer. In: Eys J van, Sullivan MP, eds. Status of the curability of childhood cancers. New York: Raven Press, 1980.

Postma A, Berendt H, Groot-Loonen JJ, et al. Iatrogene gevolgen van kanker op de kinderleeftijd. Tijdschr Kindergeneeskd. 1999;5:219-23.

Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163-72.PubMed

Möller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol. 2001;19:3173-81.PubMed

Wallace WH, Green DM. Late effects of childhood cancer. London: Arnold, 2004.

Schwartz CL, Hobbie WL, Constine LS, Ruccione KS. Survivors of childhood and adolescent cancer; a multidisciplinary approach. Berlin: Springer, 2005.CrossRef

Grenier MA, Lipschultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol. 1998;25 (suppl):72-85.PubMed

Kremer LC, Dalen EC van, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001;19:191-6.PubMed

Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-15.PubMedCrossRef

Silber JH, Cnaan A, Clark BJ, et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol. 2002;22:820-8.CrossRef

Adams MJ, Hardenberg PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45:55-75.CrossRefPubMed

Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, et al. Ischemic heart disease after mantlefield irradiation of Hodgkin's disease in long-term follow-up. Radiother Oncol. 1999;51:35-42.CrossRefPubMed

Neglia JP, Griedman DL, Yasu Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Nat Cancer Inst. 2001;93:618-29.CrossRefPubMed

Walter AW, Hancock ML, Pui CH, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol. 1998;16:3761-7.PubMed

Bhatia S, Yasiu Y, Robison LL. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the late effects study group. J Clin Oncol. 2003;21:4386-94nd>/nd>CrossRefPubMed

Lai R, Crevier L, Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumor: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14: 1784-90.CrossRefPubMed

Landier W, Wallace WHB, Hudson MM. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatr Blood Cancer. 2006;46:149-58.CrossRef

Wallace WHB, Blacklay A, Eiser C, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 2001;323:271-4.CrossRefPubMed

Goldsby RE, Ablin AR. Surviving childhood cancer; now what? Controversies regarding long-term follow-up. Pediatr Blood Cancer. 2004;43:211-4.CrossRefPubMed

Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer. 2006;46:143-8.CrossRef

Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46: 159-68.CrossRef

Jaspers MWM, Bos C van den, Heinen RC, et al. Development of a national protocol to screen Dutch cancer survivors on late cancer treatment effects. Int J Med Inform. 2006 Mar 11; [Epub ahead of print].

Kremer LCM, Jaspers MWM, Leeuwen FE van, et al. Landelijke richtlijnen voor follow-up van overlevenden van kinderkanker. Tijdschr Kindergeneeskd. 2006;74:214-8.

Oeffinger KC, Wallace WHB. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer. 2006;46:135-42.CrossRef

Hawkins MM, Robison LL. Importance of clinical and epidemiological research in defining the long-term clinical care of pediatric cancer survivors. Pediatr Blood Cancer. 2006;46: 174-8.CrossRef

Titel: Gezondheidsproblemen na de behandeling van kinderkanker
Auteurs: A. Postma
A. Y. N. Schouten-van Meeteren
F. G. A. J. Hakvoort-Cammel
D. Bresters
A. B. Versluys
J. P. M. Bökkerink
E. van Dulmen-den Broeder
H. J. H. van der Pal
E. W. C. M. van Dam
G. H. M. van der Linden
R. Blaauwbroek
F. E. van Leeuwen
M. W. M. Jaspers
L. C. M. Kremer
C. van den Bos
Publicatiedatum: 01-12-2006
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Tijdschrift voor Kindergeneeskunde / Uitgave 6/2006
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI: https://doi.org/10.1007/BF03061641

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2006

Nazorg Intensive Care Opname (nico): gestructureerde follow-up van fysieke en psychische gevolgen

Aangeboren hartafwijkingen op volwassen leeftijd

Cystic fibrosis; een vergrijzend ziektebeeld?

Respiratory mechanics in ventilated preterm infants: early determinants and outcome

Late effecten na behandeling van een chronische of ernstige ziekte op de kinderleeftijd

Landelijke richtlijnen voor follow-up van overlevenden van kinderkanker